Resilient Lifescience
PrivateLast Round
Grant
Sep 23, 2024
Est. Valuation
$5M
Total Funding Raised
$3.72M
Company Overview
Resilient Lifescience operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Grant round in September 2024.
Resilient Lifescience is a medical devices company developing a wearable patch that automatically detects and reverses an opioid overdose by delivering naloxone.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resilient Lifescience Comparables
Compare Resilient Lifescience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZEM Life Device Company | 91% | |
| Rescue Biomedical LLC | 86% | |
| Ayuda Medical | 76% |
For institutional investors. Book with your work email.
Resilient Lifescience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 23, 2024 | ||||
| Accelerator | Dec 6, 2023 | ||||
| VC Round | Feb 7, 2023 | ||||
| Pre Seed | May 16, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Resilient Lifescience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlphaLab Health | Accelerator |
| NIH RADx | Grant |
| Richard King Mellon Foundation | VC Round |
| Tau Ventures | Pre Seed |
| Chuangxin Innovation Works | Accelerator |
Resilient Lifescience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Resilient Lifescience's valuation, stock price, and market status.
Is Resilient Lifescience a public or private company?
Resilient Lifescience is a private company.
What is the current stock price of Resilient Lifescience?
Resilient Lifescience is a private company, so its shares have no public market price. Caplight tracks Resilient Lifescience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Resilient Lifescience worth (valuation)?
Resilient Lifescience's valuation is estimated at $5.0M based on funding round data.
Can I buy Resilient Lifescience stock?
Resilient Lifescience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Resilient Lifescience's last funding round?
Resilient Lifescience's most recent funding round was Grant on September 23, 2024.
Who are the main investors in Resilient Lifescience?
Key investors in Resilient Lifescience include Richard King Mellon Foundation.
Will Resilient Lifescience IPO soon?
No public IPO plans have been announced for Resilient Lifescience.
How can I track Resilient Lifescience secondary market activity?
Caplight tracks bids, offers, and trades in Resilient Lifescience's shares on secondary markets.